1. 36LBA Pathological response to neoadjuvant 5-FU, oxaliplatin and docetaxel (FLOT) versus epirubicin, cisplatin and 5-FU (ECF) in patients with locally advanced, resectable gastric/esophagogastric junction (EGJ) cancer: Data from the phase II part of the FLOT4 phase III study of the AIO. Issue 3 (September 2015) Authors: Pauligk, C.; Tannapfel, A.; Meiler, J.; Luley, K.B.; Kopp, H.G.; Homann, N.; Hofheinz, R.D.; Schmalenberg, H.; Probst, S.; Haag, G.M.; Egger, M.; Behringer, D.M.; Stoehlmacher, J.; Prasnikar, N.; Block, A.; Trojan, J.; Folprecht, G.; Pohl, M.; Schirmacher, P.; Al-Batran, S.E. Journal: European journal of cancer Issue: Volume 51:Issue 3(2015:Feb.) Page Start: S728 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 3D micro-tumors for predicting individual treatment responses to immunotherapy. (March 2019) Authors: Sturmheit, T.; Stamm, H.; Stange, I.; Köllmann, S.; Failla, A.V.; Thastrup, J.; Fiedler, W.; Kupper, J.; Block, A. Journal: European journal of cancer Issue: Volume 110(2019)Supplement 1 Page Start: S14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effects of inflammatory markers and biographical stress on treatment response in depression. (September 2021) Authors: Block, A.; Schulze, S.; Deeken, F.; Häusler, A.; Rezo, A.; Rapp, M.A.; Wippert, P.M. Journal: Psychoneuroendocrinology Issue: Volume 131(2021)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Onset of fast ice flow in Recovery Ice Stream, East Antarctica: a comparison of potential causes. Issue 223 (2014) Authors: Langley, K.; Tinto, K.; Block, A.; Bell, R.; Kohler, J.; Scambos, T. Journal: Journal of Glaciology Issue: Volume 60:Issue 223(2014) Page Start: 1007 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P1456: EARLY SAFETY AND CLINICAL COURSE OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MEASURABLE RESIDUAL DISEASE RECEIVING GTA002, AN OFF-THE-SHELF, EX VIVO-CULTURED ALLOGENEIC NK CELL PREPARATION. (23rd June 2022) Authors: Heuser, M.; Fiedler, W.; Block, A.; de Leeuw, D. C.; van de Loosdrecht, A.; Astrid Tschan-Plessl, A.; Passweg, J.; Kloos, A.; Schwarzer, A.; Venturini, L.; Duru, A. D.; Pinkernell, K.; Ganser, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1338 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SAT0001 Antibody Response to Pneumococcal and Influenza Vaccination in Patients With RA Receiving Subcutaneous Abatacept. (23rd January 2014) Authors: Alten, R.; Bingham, C. O.; Cohen, S.; Calabrese, L.; Curtis, J. R.; Block, A.; Fay, J.; Kelly, S.; Luo, A.; Wong, D.; Genovese, M. C. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A579 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The GABAAα5-selective Modulator, RO4938581, Rescues Protein Anomalies in the Ts65Dn Mouse Model of Down Syndrome. (21st February 2018) Authors: Block, A.; Ahmed, Md.M.; Rueda, N.; Hernandez, M.-C.; Martinez-Cué, C.; Gardiner, K.J. Journal: Neuroscience Issue: Volume 372(2018) Page Start: 192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗